Martin F. Fey

Martin F. Fey publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Martin F. Fey sits on this spectrum.

Martin F. Fey D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin F. Fey sits on this spectrum.

Best Publications

• Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

  Jan J. Cornelissen;Wim L. J. van Putten;Leo F. Verdonck;Matthias Theobald

  635
  Citations

• Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

  Bob Löwenberg;Wim van Putten;Matthias Theobald;Jurg Gmür

  505
  Citations

• Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53.

  Unknown

  467
  Citations

• Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation.

  Sibylla Martinelli;Mirjana Urosevic;Arezoo Daryadel;Patrick Antony Oberholzer

  331
  Citations

• Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

  Unknown

  329
  Citations

• ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression

  Beatrice U. Mueller;Thomas Pabst;José Fos;Vibor Petkovic

  267
  Citations

• High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.

  S K Metzelder;T Schroeder;A Finck;S Scholl

  262
  Citations

• Inflammation-associated Cell Cycle–independent Block of Apoptosis by Survivin in Terminally Differentiated Neutrophils

  Frank Altznauer;Sibylla Martinelli;Shida Yousefi;Christine Thürig

  237
  Citations

• The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis

  Bronno van der Holt;Bob Löwenberg;Alan K Burnett;Wolfgang U Knauf

  228
  Citations

• Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia

  Fenaux P;Chevret S;Guerci A;Fegueux N

  220
  Citations

• Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.

  Stéphane de Botton;Sylvie Chevret;Miguel Sanz;Hervé Dombret

  208
  Citations

• Autophagy is required for self-renewal and differentiation of adult human stem cells.

  Souzan Salemi;Shida Yousefi;Mihai A Constantinescu;Martin F Fey

  195
  Citations

• Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.

  B. Löwenberg;M. A. Boogaerts;S. M. G. J. Daenen;G. E. G. Verhoef

  185
  Citations

• Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.

  S. de Botton;A. Fawaz;S. Chevret;H. Dombret

  179
  Citations

• Outcome of Childhood Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid and Chemotherapy

  S. de Botton;V. Coiteux;S. Chevret;C. Rayon

  179
  Citations

• Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK).

  C Rochlitz;A Lohri;M Bacchi;M Schmidt

  153
  Citations

• Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A)

  G Kostylina;D Simon;M F Fey;S Yousefi

  151
  Citations

• Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years

  J J Cornelissen;J Versluis;J R Passweg;W L J van Putten

  150
  Citations

• Extramedullary relapse in acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy

  S de Botton;M A Sanz;S Chevret;H Dombret

  147
  Citations

• Acute myeloblastic leukaemias in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Martin Fey;C. Buske

  141
  Citations